Lancet Diabetes Endocrinol
-
Publication Venue For
-
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial..
10:869-881.
2022
-
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials..
9:653-662.
2021
-
GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs..
9:640-641.
2021
-
2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial..
7:673-683.
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial..
7:618-628.
2019
-
Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial..
6:934-943.
2018
-
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis..
6:105-113.
2018
-
Corrections needed to 2016 ESC and AHA guidelines on heart failure..
5:325-326.
2017
-
An internet-based intervention with brief nurse support to manage obesity in primary care (POWeR+): a pragmatic, parallel-group, randomised controlled trial..
4:821-828.
2016
-
Heart failure event definitions in drug trials in patients with type 2 diabetes..
4:294-296.
2016
-
mHealth: only as good as the company it keeps..
4:7-8.
2016
-
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants..
3:624-637.
2015
-
Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer..
3:545-555.
2015
-
Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study..
2:701-709.
2014